Biofilm Modified Macrophage Phenotype and Function in Diabetic Wound Healing
NCT03271580 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 31
Last updated 2024-04-25
Summary
The purpose of this study is to learn more about biofilm and to see how it affects diabetic wounds. A biofilm can occur if a chronic infection causes bacteria to grow in a slime enclosed group. This grouping of bacteria is called a biofilm.
Conditions
- Wound
- Bacterial Infections
- Diabetes Mellitus
- Infected Ulcer of Skin
Interventions
- DIAGNOSTIC_TEST
-
Finger prick test for HbA1c measurement
HbA1c measurement with finger prick method
- PROCEDURE
-
Punch Biopsy
Wound site will be anaesthetized, by punch biopsy tissue will be collected, wound site will be monitored for bleeding(if bleeding Cautery will be used to stop bleeding).
- OTHER
-
Vac Sponge Collection
NPWT sponge which is discarded as biological waste, will be collected for wound macrophage isolation
- OTHER
-
Ankle Brachial Index
Blood pressure test
Sponsors & Collaborators
-
Indiana University
lead OTHER
Principal Investigators
-
Sashwati Roy, PhD · Indiana University
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-02-01
- Primary Completion
- 2021-09-13
- Completion
- 2021-09-13
Countries
- United States
Study Locations
More Related Trials
-
Evaluation of Wound Biofilm in Acute and Chronic Wounds
NCT00764348 ·Status: WITHDRAWN
-
Diabetic Foot Ulcer (DFU) Rapid Pathogen Identification
NCT06569238 ·Status: COMPLETED ·Phase: NA
-
Topical Oxygen Therapy for Diabetic Wounds
NCT02313428 ·Status: TERMINATED ·Phase: NA
-
Evaluating Safety and Biological Effect on Wound Healing of ILP100-Topical in Subjects With Diabetic Foot Ulcers
NCT05608187 ·Status: TERMINATED ·Phase: PHASE2
-
Effect of Platelet Concentrate in Treatment of Diabetic Ulcers
NCT00215735 ·Status: TERMINATED ·Phase: NA
-
C-myc Biomarker Study for Diabetic Foot Ulcers
NCT04591691 ·Status: COMPLETED
-
Prevention of Infection Using a Topical Gentamicin-Collagen Sponge in Diabetic Patients With An Uninfected Foot Ulcer
NCT00658957 ·Status: TERMINATED ·Phase: PHASE2
-
miR-200b & miR-21 in Diabetic Wounds
NCT02581098 ·Status: COMPLETED
-
Sterilised, Porcine Placental Tissue in the Treatment of Chronic Diabetic Foot Ulcers
NCT05687656 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
ECM and Blood Components for Wound Healing
NCT01909908 ·Status: TERMINATED ·Phase: NA
-
Macrophage Stimulating Factor in the Treatment of Diabetic Wounds
NCT06608303 ·Status: COMPLETED ·Phase: NA
-
Use of AC5® Advanced Wound System in the Treatment of Diabetic Foot Ulcers
NCT06028386 ·Status: UNKNOWN ·Phase: NA
-
Obtaining and Storing Standard of Care Wound Biopsies for Immediate or Future Wound-Related Scientific Study
NCT00759889 ·Status: COMPLETED
-
Immunonutrition for Diabetic Foot Ulcers
NCT05281562 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
Safety and Efficacy Study of an Interactive Wound Dressing (KC002) for the Treatment of Diabetic Foot Ulcers
NCT00330265 ·Status: UNKNOWN ·Phase: PHASE2
-
The Mechanism of Action of the Unite Biomatrix in Diabetic Foot Ulcer
NCT00958711 ·Status: TERMINATED ·Phase: NA
-
Study of a Topical Gentamicin-Collagen Sponge Along With Systemic Antibiotic in Infected Diabetic Foot Ulcers
NCT02427802 ·Status: COMPLETED ·Phase: PHASE3
-
Acellular Dermal Allograft for Chronic Diabetic Wounds
NCT06227520 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Local Application of Autologous Bone Marrow Cells for Treatment of Chronic Diabetic Ulcers
NCT00292357 ·Status: UNKNOWN ·Phase: PHASE1
-
A Clinical Evaluation of a Honey Impregnated Dressing at Removing Necrotic Tissue From Chronic Wounds
NCT03412929 ·Status: TERMINATED ·Phase: NA
-
Treatment of Chronic Wounds in Diabetic Foot Syndrome With Allogeneic Adipose Derived Mesenchymal Stem Cells
NCT03865394 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
MIRODERM H2H DFU Study
NCT03232333 ·Status: COMPLETED
-
Effect of Meso Wound Matrix in the Treatment of DFUs
NCT04182451 ·Status: COMPLETED ·Phase: NA
-
Diabetic Foot Ulcer Study Comparing Cytal Wound Matrix 1-Layer to Standard of Care
NCT03626623 ·Status: TERMINATED ·Phase: NA
-
A Phase 2a Proof of Concept Open-Label, Randomized, Controlled Study to Evaluate the Safety and Efficacy of MDI-1228-mesylate Gel Compared With Standard of Care Alone in Patients With Diabetic Foot Ulcers
NCT06852976 ·Status: RECRUITING ·Phase: PHASE2